New dimension in therapeutic targeting of BCL-2 family proteins
- PMID:25970783
- PMCID: PMC4536985
- DOI: 10.18632/oncotarget.3868
New dimension in therapeutic targeting of BCL-2 family proteins
Abstract
Proteins of the BCL-2 family control the mitochondrial pathway of apoptosis. Targeting these proteins proves to be an attractive strategy for anticancer therapy. The biological context is based on the fact that BH3-only members of the family are specific antagonists of prosurvival members. This prompted the identification of "BH3 mimetic" compounds. These small peptides or organic molecules indeed mimic the BH3 domain of BH3-only proteins: by selectively binding and antagonizing prosurvival proteins, they can induce apoptosis in malignant cells. Some small-molecule inhibitors of prosurvival proteins have already entered clinical trials in cancer patients and two of them have shown significant therapeutic effects. The latest developments in the field of targeting BCL-2 family proteins highlight several new antagonists of prosurvival proteins as well as direct activators of proapoptotic proteins. These compounds open up novel prospects for the development of BH3 mimetic anticancer drugs.
Keywords: BH3 mimetics; anticancer therapy; apoptosis; prosurvival protein antagonists; targeting BCL-2 family proteins.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Similar articles
- BH3 mimetics: status of the field and new developments.Billard C.Billard C.Mol Cancer Ther. 2013 Sep;12(9):1691-700. doi: 10.1158/1535-7163.MCT-13-0058. Epub 2013 Aug 23.Mol Cancer Ther. 2013.PMID:23974697Review.
- Development of Noxa-like BH3 mimetics for apoptosis-based therapeutic strategy in chronic lymphocytic leukemia.Billard C.Billard C.Mol Cancer Res. 2012 Jun;10(6):673-6. doi: 10.1158/1541-7786.MCR-12-0015. Epub 2012 Mar 30.Mol Cancer Res. 2012.PMID:22466256
- Small-molecule inhibitors of Bcl-2 family proteins are able to induce tumor regression in a mouse model of pre-B-cell acute lymphocytic lymphoma.Turner BC, Eves T, Refaeli Y.Turner BC, et al.DNA Cell Biol. 2008 Mar;27(3):133-42. doi: 10.1089/dna.2007.0675.DNA Cell Biol. 2008.PMID:18163880
- Targeting ERK1/2-bim signaling cascades by BH3-mimetic ABT-737 as an alternative therapeutic strategy for oral cancer.Shin JA, Kim LH, Lee SJ, Jeong JH, Jung JY, Lee HN, Hong IS, Cho SD.Shin JA, et al.Oncotarget. 2015 Nov 3;6(34):35667-83. doi: 10.18632/oncotarget.5523.Oncotarget. 2015.PMID:26447615Free PMC article.
- Design of novel BH3 mimetics for the treatment of chronic lymphocytic leukemia.Billard C.Billard C.Leukemia. 2012 Sep;26(9):2032-8. doi: 10.1038/leu.2012.88. Epub 2012 Mar 28.Leukemia. 2012.PMID:22453662Review.
Cited by
- Sanguinarine inhibits growth and invasion of gastric cancer cells via regulation of the DUSP4/ERK pathway.Zhang R, Wang G, Zhang PF, Zhang J, Huang YX, Lu YM, Da W, Sun Q, Zhu JS.Zhang R, et al.J Cell Mol Med. 2017 Jun;21(6):1117-1127. doi: 10.1111/jcmm.13043. Epub 2016 Dec 13.J Cell Mol Med. 2017.PMID:27957827Free PMC article.
- Apoptosis and autophagy induced by pyropheophorbide-α methyl ester-mediated photodynamic therapy in human osteosarcoma MG-63 cells.Huang Q, Ou YS, Tao Y, Yin H, Tu PH.Huang Q, et al.Apoptosis. 2016 Jun;21(6):749-60. doi: 10.1007/s10495-016-1243-4.Apoptosis. 2016.PMID:27108344Free PMC article.
- Orientin Induces G0/G1 Cell Cycle Arrest and Mitochondria Mediated Intrinsic Apoptosis in Human Colorectal Carcinoma HT29 Cells.Thangaraj K, Balasubramanian B, Park S, Natesan K, Liu W, Manju V.Thangaraj K, et al.Biomolecules. 2019 Aug 27;9(9):418. doi: 10.3390/biom9090418.Biomolecules. 2019.PMID:31461995Free PMC article.
- Shedding Light on the Interaction of Human Anti-Apoptotic Bcl-2 Protein with Ligands through Biophysical and in Silico Studies.Ramos J, Muthukumaran J, Freire F, Paquete-Ferreira J, Otrelo-Cardoso AR, Svergun D, Panjkovich A, Santos-Silva T.Ramos J, et al.Int J Mol Sci. 2019 Feb 16;20(4):860. doi: 10.3390/ijms20040860.Int J Mol Sci. 2019.PMID:30781512Free PMC article.
- Survival control of malignant lymphocytes by anti-apoptotic MCL-1.Fernández-Marrero Y, Spinner S, Kaufmann T, Jost PJ.Fernández-Marrero Y, et al.Leukemia. 2016 Nov;30(11):2152-2159. doi: 10.1038/leu.2016.213. Epub 2016 Aug 1.Leukemia. 2016.PMID:27479182Review.
References
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674. - PubMed
- Baell JB, Huang DCS. Prospects for targeting the Bcl-2 family of proteins to develop novel cytotoxic drugs. Biochem Pharmacol. 2002;64:851–863. - PubMed
- Lessene G, Czabotar PE, Colman PM. Bcl-2 family antagonists for cancer therapy. Nature Rev. 2008;7:989–1000. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources